What is the effect of area size when using local area practice style as an instrument?
- PMID: 23849157
- PMCID: PMC3718893
- DOI: 10.1016/j.jclinepi.2013.04.008
What is the effect of area size when using local area practice style as an instrument?
Abstract
Objectives: Discuss the tradeoffs inherent in choosing a local area size when using a measure of local area practice style as an instrument in instrumental variable estimation when assessing treatment effectiveness.
Study design: Assess the effectiveness of angiotensin converting-enzyme inhibitors and angiotensin receptor blockers on survival after acute myocardial infarction for Medicare beneficiaries using practice style instruments based on different-sized local areas around patients. We contrasted treatment effect estimates using different local area sizes in terms of the strength of the relationship between local area practice styles and individual patient treatment choices; and indirect assessments of the assumption violations.
Results: Using smaller local areas to measure practice styles exploits more treatment variation and results in smaller standard errors. However, if treatment effects are heterogeneous, the use of smaller local areas may increase the risk that local practice style measures are dominated by differences in average treatment effectiveness across areas and bias results toward greater effectiveness.
Conclusion: Local area practice style measures can be useful instruments in instrumental variable analysis, but the use of smaller local area sizes to generate greater treatment variation may result in treatment effect estimates that are biased toward higher effectiveness. Assessment of whether ecological bias can be mitigated by changing local area size requires the use of outside data sources.
Keywords: Acute myocardial infarction; Angiotensin converting enzyme inhibitors and angiotensin receptor blockers; Instrumental variables; Local area practice styles; Local average treatment effects; Survival.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.Pharmacotherapy. 2018 Jan;38(1):29-41. doi: 10.1002/phar.2051. Epub 2017 Dec 11. Pharmacotherapy. 2018. PMID: 29059475 Free PMC article.
-
Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.Am Heart J. 1999 Jan;137(1):79-92. doi: 10.1016/s0002-8703(99)70462-x. Am Heart J. 1999. PMID: 9878939
-
Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.J Am Coll Cardiol. 2003 Jul 16;42(2):201-8. doi: 10.1016/s0735-1097(03)00572-2. J Am Coll Cardiol. 2003. PMID: 12875751
-
[Practice of antihypertensive treatment in diabetic patients with hypertension in Hungary].Orv Hetil. 2014 Oct 26;155(43):1695-700. doi: 10.1556/OH.2014.29988. Orv Hetil. 2014. PMID: 25327459 Review. Hungarian.
-
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk.Am J Cardiovasc Drugs. 2016 Dec;16(6):399-406. doi: 10.1007/s40256-016-0185-0. Am J Cardiovasc Drugs. 2016. PMID: 27580998 Free PMC article. Review.
Cited by
-
Effect of hospital assignment on mortality for AMI patients.BMC Health Serv Res. 2023 Apr 29;23(1):413. doi: 10.1186/s12913-023-09441-4. BMC Health Serv Res. 2023. PMID: 37120541 Free PMC article.
-
Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction.Pharmacy (Basel). 2022 Nov 3;10(6):147. doi: 10.3390/pharmacy10060147. Pharmacy (Basel). 2022. PMID: 36412823 Free PMC article.
-
Assessing the ability of an instrumental variable causal forest algorithm to personalize treatment evidence using observational data: the case of early surgery for shoulder fracture.BMC Med Res Methodol. 2022 Jul 11;22(1):190. doi: 10.1186/s12874-022-01663-0. BMC Med Res Methodol. 2022. PMID: 35818028 Free PMC article.
-
Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project.BMJ Open. 2021 Jan 19;11(1):e041698. doi: 10.1136/bmjopen-2020-041698. BMJ Open. 2021. PMID: 33468528 Free PMC article.
-
Association of Surgical Treatment With Adverse Events and Mortality Among Medicare Beneficiaries With Proximal Humerus Fracture.JAMA Netw Open. 2020 Jan 3;3(1):e1918663. doi: 10.1001/jamanetworkopen.2019.18663. JAMA Netw Open. 2020. PMID: 31922556 Free PMC article.
References
-
- Sox HC, Goodman SN. The Methods of Comparative Effectiveness Research. Annu Rev Publ Health. 2012;33:425–445. - PubMed
-
- Brooks JM. Supplement 1. Improving Characterization of Study Populations: the Identification Problem. In: Velentgas P, Dreyer NA, editors. Developing a Protocol for Observational Comparative Effectiveness Research (OCER): A User’s Guide. 12-EHC099. Rockville, MD: Agency for Healthcare Research and Quality; 2012. (Prepared by Outcome DEcIDE Center [Quintiles Outcome] under Contract No. HHSA29020050016I TO10) - PubMed
-
- Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000 Dec;29(6):1102. - PubMed
-
- Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998;19:17–34. - PubMed
-
- McMahon AD. Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Saf. 2003 Oct-Nov;12(7):551–558. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
